Rami Levin
President & Chief Executive Officer at CNS Pharmaceuticals
Greater Boston
Find your path to Rami
383 people in our graph can introduce you to Rami.
Sign up to see every warm intro you have to Rami
- Paths you didn't know you had: your email and LinkedIn already hold routes to Rami. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Experience
- CNS Pharmaceuticals, Inc.President & Chief Executive Officercurrent2025 — presentGreater Boston Area
- GENerX LifeMember of the Board2024 — 2025
- The Outcomes GroupFounder, Chief Executive Officer2024 — 2025Greater Boston Area
- ImStem Biotechnology, IncChief Executive Officer2022 — 2024Greater Boston
- SanionaPresident & Chief Executive Officer2019 — 2022Greater Boston
- Life Science Cares BostonMember of the Board of Advisors2017 — 2021Boston, Massachusetts, United States
- Sobi - North AmericaPresident2014 — 2019Greater Boston Area
- Merck GroupVice President Marketing2012 — 2014Greater Boston Area
- Merck GroupManaging Director - Scandinavia2008 — 2012Stockholm, Sweden
- Serono (Acquired by Merck KGaA)Global Marketing Head, Neurology2005 — 2008Geneva, Switzerland
- Serono (Acquired by Merck KGaA)Global Product Manager2001 — 2005Geneva, Switzerland
- Serono (Acquired by Merck KGaA)Business Unit Head1998 — 2001Israel
- Schering AGProduct Manager1997 — 1998Israel
- Schering AGSales representative1996 — 1997Israel
Skills & more
Global Alignment & Affiliate CollaborationStrategic Partnerships & Alliance ManagementBusiness Development & M&A (Gamifant®, Synagis®)Cross-functional Team Building & IntegrationCommercial Team Expansion & Management (15 to 300+ employees)Market Access & Reimbursement StrategyFDA Regulatory Strategy & Product Approval PathwaysP&L Management & Financial OversightCorporate Turnaround & Market RepositioningExecutive Leadership & Organizational Scale-UpNorth American Market Strategy & OperationsRevenue Growth & Profitability Expansion
+12 more
Rare Disease Commercialization (pHLH, RSV, Tyrosinemia)Product Launch Leadership (Gamifant®, Orfadin®)Executive Leadership & Strategic DirectionCompany Scaling & Organizational DevelopmentBiotech Fundraising (VC, Public Markets)Capital Acquisition & Investor RelationsIPO Readiness & PositioningRare Disease Drug Development (PWS, HO, Neuropathic Disorders)Orphan Drug Designation StrategyClinical Development Leadership (Phase 1 & Phase 2 Trials)Pipeline Advancement & Portfolio ManagementDrug Discovery & Translational Research OversightFrom Rami's professional profile.
Frequently asked questions
- Who is Rami Levin?
- President & Chief Executive Officer at CNS Pharmaceuticals
- Where did Rami Levin go to school?
- Rami Levin studied at Tel Aviv University (MBA, Business & International Marketing); Tel Aviv University (BSc, Biology); IMD (Executive education).
Founder mafias
INSEAD mafia419
Also came through, then founded or led a company.
Tel Aviv University mafia398
Also came through, then founded or led a company.
Northwestern University - Kellogg School of Management mafia327
Also came through, then founded or led a company.
IMD mafia100
Also came through, then founded or led a company.
Veronica Gambillara FonckMaster of Business Administration - MBAFounded LimmaTech Biologics +1Oern R. StugeMBAFounded Impulse Dynamics +1Galina AntovaMaster of Business Administration - MBAFounded Claroty +1Heatherm HuangExecutive Education ProgramFounded RewardMe +1Julie Waras BrogrenBuilding on TalentFounded Gedea Biotech +1Erik StangerupDiploma in High Performance LeadershipFounded Lotus Microsystems +1
Thunderbird School of Global Management mafia38
Also came through, then founded or led a company.
John HewittMaster of Business Administration (M.B.A.)Founded Robertshaw +1Cora LeibigExecutive educationFounded Chromatic 3D Materials Inc. +1Dhruv TanejaMaster of Business Administration (MBA)Founded Matchlog +1Jim WardM.I.M.Founded Meow WolfHoward LindzonFounded StockTwitsMatt OberFounded StockTwits
Same school
Also attended Tel Aviv University859
Arnon DinurPartner at 83NorthYoram SnirPartner at 83NorthRaz MaysharSenior Manager at Qualcomm VenturesDavid GoldschmidtManaging Director, Head of the Fund at Samsung Catalyst FundAmit ShofarSr. Investment Director at Samsung Catalyst FundRutie AdarInvestments & Innovation Sr. Director, Israel at Samsung Catalyst Fund
+ 853 more
Also attended IMD338
Karthik ChakkarapaniInvestor at Foundation CapitalKulpreet SinghOperating Advisor at OpenOceanMusaad AlkadiSr. Principal at Graphene VenturesGrant AllenFounding GP, Schneider Electric Ventures at Giant Ventures Global LlpFredric PetitPartner, Head of Materials & Packaging at Emerald Technology Ventures AgMichael ZehnderHead of Digital Technology & Intelligence at Emerald Technology Ventures Ag
+ 332 more
Also attended HKUST Business School64
Raoul Oscar FianoInvestor at DN CapitalRavi RajamonyVice President at March Capital PartnersPavel TinkovGeneral Partner & Founder at AUDEO VENTURESCatherine Ouellet-DupuisGeneral Partner at White Star CapitalAndreas HadjitofiAssociate at Quadri VenturesCarey LaiCo-Founder & General Partner at Conductive Ventures
+ 58 more
Also attended Northwestern University - Kellogg School of Management1,229
Jenny LeeSenior Managing Partner at Granite AsiaKunal BahlCo-founder of Snapdeal; co-founder of Titan CapitalCristina JunqueiraCo-founder of NubankAndy FligelSenior Managing Director at Intel CapitalDavid Clark GuillermoInvestments at Impact America FundGiuseppe DonvitoPartner at P101 Ventures
+ 1,223 more
Shared employers
Also worked at Life Science Cares Boston5
Deborah PalestrantPartner, Executive Chair, 4:59 Initiative at 5AM VenturesMichelle DetwilerManaging Partner, MD, PhD at BIOSPRING PARTNERSGeoff McDonoughExecutive Team / Board at NodtheraThomas CavanaghExecutive Officer at Aciex TherapeuticsKara ColuccioHead of Talent Acquisition & Strategy at RA Capital


































































